Provided by Tiger Trade Technology Pte. Ltd.

WUXI BIO

48.840
-1.810-3.57%
Volume:47.44M
Turnover:2.30B
Market Cap:202.44B
PE:36.07
High:50.200
Open:49.020
Low:47.820
Close:50.650
52wk High:54.450
52wk Low:28.480
Shares:4.15B
HK Float Shares:4.15B
Volume Ratio:0.86
T/O Rate:1.14%
Dividend:- -
Dividend Rate:- -
EPS(LYR):1.354
ROE:11.38%
ROA:7.60%
PB:3.61
PE(LYR):36.07
PS:7.34

Loading ...

WuXi Biologics files HKEX next-day disclosure return on share repurchase for cancellation

Reuters
·
Jun 09

WUXI BIO Grants 288,400 Restricted Shares

Stock News
·
Jun 09

Wuxi Biologics (Cayman) Stock Sheds 1.4% in Hong Kong

Dow Jones
·
Jun 09

Movement Alert|WuXi Biologics Falls 3.09% in Regular Trading, CXO Sector Extends Multi-Day Selloff Amid US Biosecurity Legislation Concerns

Market Focus
·
Jun 09

Key Corporate Developments and Share Repurchases Highlight Hong Kong Market Activity

Stock News
·
Jun 09

WUXI BIO Executes HK$200 Million Share Repurchase on June 8

Stock News
·
Jun 08

Wuxi Biologics (Cayman) Stock Slides 7.2% in Hong Kong

Dow Jones
·
Jun 08

Assessing WuXi Biologics (SEHK:2269) Valuation After Its Recent Share Price Momentum Shift

Simply Wall St.
·
Jun 07

Is WuXi Biologics (SEHK:2269) Offering Value After Its Recent Share Price Recovery?

Simply Wall St.
·
Jun 06

WUXI BIO Executes Major Share Buyback, Spending Nearly HK$100 Million

Stock News
·
Jun 05

WuXi Biologics tops out Singapore modular drug product facility, targets 100 million units annual output

Reuters
·
Jun 05

HK Movers | Biotech Stocks Jump. Asymchem up Nearly 7%; SKB Bio up About 6%; Hengrui Pharma, Pharmaron, InnoGen up over 4%; Wuxi Apptec up 3%; Laekna, Joinn, Remegen up over 2%

Tiger Newspress
·
Jun 05

Movement Alert|WuXi Biologics Rises 3.7% in Regular Trading, USD 400 Million Buyback Ongoing as CICC Maintains HKD 48 Target Price

Market Focus
·
Jun 05

TOT Biopharm proposes Deloitte as new auditor as PwC retires

Reuters
·
Jun 04

WUXI BIO Issues 0.10 Million New Shares Under Pre-IPO Options, Repurchases 1.51 Million Shares for HKD 49.89 Million

Bulletin Express
·
Jun 03

WUXI BIO Executes Share Buyback, Spending Nearly HK$50 Million on June 3

Stock News
·
Jun 03

WuXi Biologics Reports Marginal Share Increase and Ongoing Buyback in May 2026 Monthly Return

Bulletin Express
·
Jun 03

Major Tech and Pharma Stocks Decline in Hong Kong Market

Deep News
·
Jun 03

WuXi Biologics makes CDP Supplier Engagement Assessment A List for second straight year

Reuters
·
Jun 03

Movement Alert|WuXi Biologics Declines 3.36% in Regular Trading, Trading at 33.66 HKD

Market Focus
·
Jun 03